Basic and Clinical Neuroscience (Oct 2015)

Case Report: Combination Therapy with Mesenchymal Stem Cells and Granulocyte-Colony Stimulating Factor in a Case of Spinal Cord Injury

  • Nazi Derakhshanrad,
  • Hooshang Saberi,
  • Keyvan Tayebi Meybodi,
  • Mohammad Taghvaei,
  • Babak Arjmand,
  • Hamid Reza Aghayan,
  • Amir Hassan Kohan,
  • Mohammad Haghpanahi,
  • Shahrokh Rahmani

Journal volume & issue
Vol. 6, no. 4
pp. 299 – 305

Abstract

Read online

Introduction: Various neuroregenerative procedures have been recently employed along with neurorehabilitation programs to promote neurological function after Spinal Cord Injury (SCI), and recently most of them have focused on the acute stage of spinal cord injury. In this report, we present a case of acute SCI treated with neuroprotective treatments in conjunction with conventional rehabilitation program. Methods: A case of acute penetrative SCI (gunshot wound), 40 years old, was treated with intrathecal bone marrow derived stem cells and parenteral Granulocyte-Colony Stimulating Factor (G-CSF) along with rehabilitation program. The neurological outcomes as well as safety issues have been reported. Results: Assessment with American Spinal Injury Association (ASIA), showed neurological improvement, meanwhile he reported neuropathic pain, which was amenable to oral medication. Discussion: In the acute setting, combination therapy of G-CSF and intrathecal Mesenchymal Stem Cells (MSCs) was safe in our case as an adjunct to conventional rehabilitation programs. Further controlled studies are needed to find possible side effects, and establish net efficacy.

Keywords